FDA weighs expanding dietary supplement ingredients as makers push peptides, probiotics and other wellness products amid calls to ease red tape and rules.
Researchers analyzing millions of safety reports identified a possible link between a popular obesity drug and an increased reporting of “eye stroke,” a condition tied to reduced blood flow to the ...
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly alternative.
A new oral GLP-1 therapy and the first preventive option for COVID-19 are among the pipeline drugs that payers and plan sponsors should be watching this spring, according to a new report. The pipeline ...
Pharmaceutical Technology on MSN
J&J’s Darzalex nets first self-administered cancer injectable approval
This approval will further enhance Darzalex’s penetration of the multiple myeloma market.
French drugmaker Sanofi said on Friday the European Medicines Agency has recommended the approval of a subcutaneous version ...
Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- Awiqli(R) offers adults with type 2 diabetes an alternative to daily basal insulin ...
The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control blood sugar levels ...
To build their first flock of engineered chickens, the Neion Bio team inserted genes into primordial germ cells to produce a ...
A Florida woman was convicted in connection with the death of a social media model to whom she had given silicone injections, ...
The FDA approves Wegovy HD (semaglutide 7.2 mg) for chronic weight management in adults with obesity or overweight and weight-related conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results